Last reviewed · How we verify

NCT04183673

Laser + Cryo-thermal Therapy Following Total Knee Replacement Surgery

Completed NA Last updated 1 April 2022
What this trial tests

NA trial testing Laser therapy-cryo thermal therapy in Knee Arthropathy in 68 participants. Completed in 28 February 2019.

Timeline
29 May 2018
Primary endpoint
31 January 2019
28 February 2019

Quick facts

Lead sponsorIstituti Clinici Scientifici Maugeri SpA
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment68
Start date29 May 2018
Primary completion31 January 2019
Estimated completion28 February 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Who can join

Adults 50 to 85, any sex, with Knee Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective To investigate the effectiveness of the use of the QMD Helios Laser device in association with standard rehabilitation therapy in reducing inflammatory symptoms in patients following total knee replacement. Design Randomized controlled trial. Setting Rehabilitation structure, inpatient Main outcome measures Pain subscale of the WOMAC and Lequesne's Algo-Functional Index (LIKERT scale), knee circumference (measured at the middle line of the knee joint space) and knee flexion /extension range of motion by goniometer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Arthropathy

Currently open trials in the same condition.

Other Istituti Clinici Scientifici Maugeri SpA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04183673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing